260.4

-0.04%↓

SAN

80.44

+1.26%↑

MRK1

110.85

0%↓

SHL.DE

47.2

-0.32%↓

ARGX

648.8

+0.4%↑

260.4

-0.04%↓

SAN

80.44

+1.26%↑

MRK1

110.85

0%↓

SHL.DE

47.2

-0.32%↓

ARGX

648.8

+0.4%↑

260.4

-0.04%↓

SAN

80.44

+1.26%↑

MRK1

110.85

0%↓

SHL.DE

47.2

-0.32%↓

ARGX

648.8

+0.4%↑

260.4

-0.04%↓

SAN

80.44

+1.26%↑

MRK1

110.85

0%↓

SHL.DE

47.2

-0.32%↓

ARGX

648.8

+0.4%↑

260.4

-0.04%↓

SAN

80.44

+1.26%↑

MRK1

110.85

0%↓

SHL.DE

47.2

-0.32%↓

ARGX

648.8

+0.4%↑

Home・Aandelen Lijst・Faes Farma SA

Faes Farma SA

Open

4.24 -1.28

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4.215

Max

4.295

Belangrijke statistieken
By Trading Economics
Inkomsten	-25M 28M
Verkoop	232M
K/W Sectorgemiddelde	12.309 35.733
Winstmarge	12.206
Werknemers	1,894
EBITDA	49M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+16.01% upside

Dividenden
By Dow Jones
Volgende Winsten	30 okt 2025

Marktinformatie
By TradingEconomics
Marktkapitalisatie	1.3B
Vorige openingsprijs	5.52
Vorige sluitingsprijs	4.24

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

4.15 / 4.275 Steun & Weerstand

Faes Farma SA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 sep 2025, 23:59 UTC

Acquisities, Fusies, Overnames

Anglo American Is in Talks to Buy Teck Resources, Bloomberg Says

8 sep 2025, 22:02 UTC

Belangrijke Marktbewegers

Microsoft Signs $17.4 Billion AI Deal With Nebius

8 sep 2025, 17:01 UTC

Belangrijke Marktbewegers

Eightco Holdings Stock Surges as Dan Ives Joins Board Amid Crypto Push

8 sep 2025, 17:01 UTC

Belangrijke Marktbewegers

Tron Shares Rise After New Investment From Bravemorning

8 sep 2025, 16:14 UTC

Belangrijke Marktbewegers

Beyond Air Shares Climb on FDA Orphan Drug Designation for Brain Cancer Treatment

8 sep 2025, 16:13 UTC

Belangrijke Marktbewegers

Dianthus Shares Whipsaw on Strong Trial Results, Safety Concerns

8 sep 2025, 23:12 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

8 sep 2025, 23:12 UTC

Marktinformatie

Global Equities Roundup: Market Talk

8 sep 2025, 23:12 UTC

Marktinformatie

Infratil's New Bull Likes Exposure to Growing Infrastructure Businesses -- Market Talk

8 sep 2025, 22:56 UTC

Marktinformatie

Worst May Be Over for New Zealand Retailers -- Market Talk

8 sep 2025, 22:23 UTC

Marktinformatie

Ebos's Near-Term Earnings Outlook Dims -- Market Talk

8 sep 2025, 21:51 UTC

Marktinformatie

AT&T Backs Outlook After EchoStar Spectrum Purchase -- Market Talk

8 sep 2025, 21:47 UTC

Belangrijke Marktbewegers

Microsoft Signs $17.4B AI Deal With Nebius

8 sep 2025, 21:33 UTC

Acquisities, Fusies, Overnames

This Quantum Pure Play Is Going Public. What Infleqtion Does Differently, Says Its CEO. -- Barrons.com

8 sep 2025, 21:20 UTC

Acquisities, Fusies, Overnames

MEG Energy Plans to Respond on or Before Sept 15 >MEG.T

8 sep 2025, 21:19 UTC

Acquisities, Fusies, Overnames

MEG Energy Special Committee and Board Will Evaluate Revised Strathcona Offer >MEG.T

8 sep 2025, 21:18 UTC

Acquisities, Fusies, Overnames

MEG Energy Acknowledges Strathcona's Intention to Revise Offer

8 sep 2025, 20:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

8 sep 2025, 19:33 UTC

Marktinformatie

Oil Futures Gain Despite Planned OPEC+ Output Increases -- Market Talk

8 sep 2025, 19:22 UTC

Marktinformatie

U.S. Natural Gas Futures Settle Higher -- Market Talk

8 sep 2025, 19:02 UTC

Marktinformatie

Dollar Lukewarm Amid Data Hiatus Ahead of August CPI -- Market Talk

8 sep 2025, 18:24 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

8 sep 2025, 18:24 UTC

Marktinformatie

Weaker Argentine Peso Profitable for Grain Producers -- Market Talk

8 sep 2025, 17:29 UTC

Marktinformatie

Mexican Inflation Seen Little Changed in August -- Market Talk

8 sep 2025, 16:59 UTC

Marktinformatie

Acquisities, Fusies, Overnames

SpaceX Spectrum Acquisition Will Create More Satellite Connection Supply, Verizon CEO Says -- Market Talk

8 sep 2025, 16:36 UTC

Marktinformatie

Crude Futures Hold Gains After OPEC+ Output Decision -- Market Talk

8 sep 2025, 16:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

8 sep 2025, 16:16 UTC

Winsten

Strategy Stock May Not Ever Make It Into the S&P 500 Index -- Barrons.com

8 sep 2025, 16:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

8 sep 2025, 16:04 UTC

Marktinformatie

Global Equities Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Faes Farma SA Prognose

Koersdoel

By TipRanks

16.01% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 5 EUR 16.01%

Hoogste 5.5 EUR

Laagste 4.5 EUR

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Faes Farma SA - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Faes Farma SA - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

4.15 / 4.275Steun & Weerstand

Bullish events outweigh bearish events.

All events are bullish.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Faes Farma SA

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.